Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients
Amount Raised
$42 Million
Round Type
Series A
MilfordHealthcareHealth CareInvestors
Description
Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients. The funding will advance the Company’s clinical and development programs, including the ongoing FASTR trial and its upcoming pivotal trial.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Reprieve Cardiovascular that raised within 45 days of this round, from Fundz verified event records.
- Enlaza Therapeutics raised $84M on April 5, 2024.
- Miach Orthopaedics raised $20M (Series B) on April 2, 2024.
- Melt Pharmaceuticals raised $24M (Series B) on April 2, 2024.
- Vaccinex raised $1.8M (Seed) on March 29, 2024.
- ByHeart raised $95M on March 28, 2024.
- Miach Orthopaedics raised $20M on March 28, 2024.
Who to call at Reprieve Cardiovascular, and when
A new round usually means Reprieve Cardiovascular is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Reprieve Cardiovascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Reprieve Cardiovascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Reprieve Cardiovascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Reprieve Cardiovascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansReprieve Cardiovascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.